相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197 Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates
Alan Kimura et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1
Brunella Brunelli et al.
VACCINE (2011)
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
P. B. Keiser et al.
VACCINE (2011)
Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
Jay Lucidarme et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Multicenter, Open-Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
Jamie Findlow et al.
CLINICAL INFECTIOUS DISEASES (2010)
Review of Meningococcal Group B Vaccines
Dan M. Granoff
CLINICAL INFECTIOUS DISEASES (2010)
Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age A Double-blind Randomized Active-controlled Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
Davide Serruto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
John Donnelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates
Rolando Pajon et al.
VACCINE (2010)
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
Marzia M. Giuliani et al.
VACCINE (2010)
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
Han-Qing Jiang et al.
VACCINE (2010)
Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles
Andrew R. Gorringe et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Challenges and progress in the development of a serogroup B meningococcal vaccine
Susan Lewis et al.
EXPERT REVIEW OF VACCINES (2009)
Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years
Yvonne Galloway et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2009)
Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
Jay Lucidarme et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine
Sharon H. Wong et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
Stefania Bambini et al.
VACCINE (2009)
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
Lisa K. McNeil et al.
VACCINE (2009)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
Factor H-binding protein, a unique meningococcal vaccine antigen
Mariagrazia Pizza et al.
VACCINE (2008)
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: Implications for the development of a multicomponent group B vaccine
Peter T. Beernink et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
P. Oster et al.
VACCINE (2007)
Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks
Muhamed-Kheir Taha et al.
VACCINE (2007)
Immunogenicity and safety of three doses of a bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents
Dominique Boutriau et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid genetic grouping of factor H-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate
Peter T. Beernink et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit
Stephen J. Gray et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB
DR Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Genetic analysis of meningococci carried by children and young adults
H Claus et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles
A Gorringe et al.
VACCINE (2005)
Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells
B Capecchi et al.
MOLECULAR MICROBIOLOGY (2005)
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
LD Fletcher et al.
INFECTION AND IMMUNITY (2004)
NadA diversity and carriage in Neisseria meningitidis
M Comanducci et al.
INFECTION AND IMMUNITY (2004)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
JA Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
NadA, a novel vaccine candidate of Neisseria meningitidis
M Comanducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Advances in immunology: Complement (First of two parts).
MJ Walport
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
分享论文
